Categories AlphaGraphs, Earnings, Technology
Earnings Summary: GameStop Q3 FY25 earnings jump; sales drop 5%
GameStop Corp. (NYSE: GME), a leading provider of video games and consumer electronics, has reported a sharp increase in adjusted earnings for the third quarter of fiscal 2025, despite a decline in sales.
- Third-quarter net sales declined to $821.0 million from $860.3 million in the prior year’s third quarter
- Net income was $77.1 million in the October quarter, compared $17.4 million in the year-ago quarter
- On a per-share basis, Q3 earnings rose sharply to $0.13 from $0.04 in the same period of FY24
- Excluding special items, adjusted net income jumped to $139.3 million in Q3 from $26.2 million last year
- Adjusted earnings per share were $0.24 per share in the third quarter, vs. $0.06 per share in Q3 2024
- Cash, cash equivalents, and marketable securities totalled $8.8 billion at the close of the third quarter
- Total Bitcoin holdings were valued at $519.4 million at the close of the third quarter
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
After a rollercoaster year, is Tesla (TSLA) stock a good bet?
In recent years, Tesla's (NASDAQ: TSLA) stock has often swung between record highs and sharp corrections, reflecting shifts in investor sentiment, broader economic conditions, and changes in its financial performance.
Dollar Tree (DLTR), Dollar General (DG): Discount stores remain key gainers in a value-conscious landscape
Discount retailers Dollar Tree, Inc. (NASDAQ: DLTR) and Dollar General Corporation (NYSE: DG) have seen their stocks gain more than 30% in the past three months. The dollar stores continue
Everything you need to know about Aktis Oncology’s upcoming IPO
IPO activity in 2025 showed a marked rebound, led by the technology and healthcare sectors, after last year's sluggish performance. Aktis Oncology, which develops radiopharmaceuticals for solid tumors, is the
